TCL Archive In Brief: NCI Awards $1.2 Million To Mt. Sinai To Establish Specialized Cancer Center July 26, 1974
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014